SEI Investments’s Allogene Therapeutics ALLO Stock Holding History

SEI Investments’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$101K	Sell	48,320 -3,632	-7%	-$7.98K	﹤0.01%	3180
2026 Q1	$127K	Buy	51,952 +3,632	+8%	+$7.28K	﹤0.01%	3054
2025 Q4	$66.2K	Hold	48,320	–	–	﹤0.01%	3055
2025 Q3	$59.9K	Hold	48,320	–	–	﹤0.01%	2765
2025 Q2	$54.6K	Hold	48,320	–	–	﹤0.01%	2744
2025 Q1	$70.5K	Hold	48,320	–	–	﹤0.01%	2647
2024 Q4	$103K	Buy	+48,320	New	+$119K	﹤0.01%	2578
2022 Q4	–	Sell	-13,864	Closed	-$150K	–	2521
2022 Q3	$150K	Buy	13,864 +1,227	+10%	+$16.7K	﹤0.01%	2513
2022 Q2	$144K	Buy	+12,637	New	+$112K	﹤0.01%	2526
2020 Q3	–	Sell	-8,950	Closed	-$383K	–	2399
2020 Q2	$383K	Buy	+8,950	New	+$324K	﹤0.01%	1971

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SEI Investments's ALLO Position: Q2 2026 in Review

SEI Investments reduced its Allogene Therapeutics (ALLO) stake by 7% in Q2 2026, selling an estimated $7.98K and leaving 48,320 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3180.

SEI Investments first reported a position in ALLO in Q2 2020 and has held it in 10 quarters since. The position peaked at $383K in Q2 2020. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

SEI Investments held 48,320 shares of Allogene Therapeutics worth $101K as of Q2 2026.
SEI Investments sold 3,632 Allogene Therapeutics shares in Q2 2026, an estimated $7.98K.
Allogene Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3180 holding.
SEI Investments first reported a position in Allogene Therapeutics in Q2 2020 and has held it in 10 quarters since.
SEI Investments's Allogene Therapeutics position peaked at $383K in Q2 2020.
209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.